Get the Stockscreener App
5.205
2.89%
-0.155
Pre-market:
5.19
-0.015
-0.29%
Cytek Biosciences Inc stock is traded at $5.205, with a volume of 875.65K.
It is down -2.89% in the last 24 hours and up +33.12% over the past month.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
See More
Previous Close:
$5.36
Open:
$5.31
24h Volume:
875.65K
Relative Volume:
0.78
Market Cap:
$665.54M
Revenue:
$193.01M
Net Income/Loss:
$-12.15M
P/E Ratio:
-57.83
EPS:
-0.09
Net Cash Flow:
$454.00K
1W Performance:
-7.05%
1M Performance:
+33.12%
6M Performance:
+53.09%
1Y Performance:
-22.20%
1-Day Range:
$4.96
$5.37
1-Week Range:
$4.96
$5.67
52-Week Range:
$2.37
$7.30
Cytek Biosciences Inc Stock (CTKB) Company Profile
Name
Cytek Biosciences Inc
Sector
Industry
Phone
(877) 922-9835
Address
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
5.205 | 685.36M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-09-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-31-25 | Downgrade | Goldman | Buy → Sell |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
View All
Cytek Biosciences Inc Stock (CTKB) Latest News
Brown Capital Management LLC Has $24.17 Million Stock Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Is Cytek Biosciences Inc. stock overvalued by current metricsJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
Can Cytek Biosciences Inc. stock beat market expectations this quarter - Newser
Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentumGDP Growth & Safe Capital Growth Plans - Newser
Why Cytek Biosciences Inc. stock attracts global investorsWeekly Trend Report & Fast Gain Stock Tips - Newser
Can Cytek Biosciences Inc. stock maintain operating marginsEarnings Growth Summary & Entry Point Strategy Guides - Newser
Is Cytek Biosciences Inc. (8EQ) stock attractive for dividend growthJuly 2025 Sentiment & Community Verified Trade Alerts - Newser
What is Cytek BioSciences Inc (CTKB) Stock Return on Shareholders’ Capital? - Setenews
Will Cytek Biosciences Inc. (8EQ) stock draw ESG focused funds2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Published on: 2025-12-02 04:27:45 - Newser
What dividend safety score for Cytek Biosciences Inc. stockPortfolio Profit Report & Long-Term Safe Investment Ideas - moha.gov.vn
Check out these key findings about Cytek BioSciences Inc (CTKB) - Setenews
Bank of Montreal Can Boosts Stock Position in Cytek Biosciences, Inc. $CTKB - Defense World
Revenues Tell The Story For Cytek Biosciences, Inc. (NASDAQ:CTKB) As Its Stock Soars 43% - simplywall.st
[Form 4] Cytek Biosciences, Inc. Insider Trading Activity - Stock Titan
Officer/Dir Yan Acquires 15,908 Of Cytek BioSciences Inc [CTKB] - TradingView
Why Cytek Biosciences Inc. stock could be next big winnerJuly 2025 Update & AI Driven Stock Reports - newser.com
Is Cytek Biosciences Inc. (8EQ) stock a good hedge against inflationJuly 2025 Summary & High Conviction Buy Zone Alerts - newser.com
Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth (CTKB) - Seeking Alpha
What technical charts say about Cytek Biosciences Inc. stockJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Cytek Biosciences, Inc. (CTKB) Stock Forecasts - Yahoo! Finance Canada
Why Cytek Biosciences Inc. (8EQ) stock is favored by hedge fundsAnalyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Check Out Cytek BioSciences Inc (CTKB)’s Trade Data Rather Than the Analysts’ Views - Setenews
What technical models suggest about Cytek Biosciences Inc.’s comeback - newser.com
Can Cytek Biosciences Inc. stock maintain growth trajectoryTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Does TIME Recognition Signal a Turning Point for Cytek Biosciences' (CTKB) Competitive Edge in Innovation? - Yahoo Finance
Cytek Biosciences (CTKB): Evaluating Valuation After TIME’s 2026 Growth Leaders Recognition and Recurring Revenue Momentum - Yahoo Finance
Cytek Biosciences Inc Stock (CTKB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cytek Biosciences Inc Stock (CTKB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McCombe William D. | Chief Financial Officer |
Jun 02 '25 |
Buy |
2.78 |
35,000 |
97,300 |
55,746 |
2.89%
4.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):